Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 44 for “"Canine Cancer"”.

  1. Regulatory T cells in canine cancer

    … with patient disease-free interval and survival. Canine Treg have previously been identified in healthy and cancer-bearing dogs and have found to be increased in the blood of dogs with some types of cancer. Moreover, some preliminary research indicates that increased numbers of Treg and decreased …

    colostate Repository record for Regulatory T cells in canine cancer (opens in a new tab)

  2. An investigation of telomerase-based diagnostic and therapeutic strategies in canine cancer

    … model in which to investigate novel anti-cancer strategies, and are genetically more similar to humans than existing mouse models. In addition, telomerase activity in humans is more closely paralleled by telomerase activity in dogs than mice, adding to the value of this model. For these …

    glasgow Repository record for An investigation of telomerase-based diagnostic and therapeutic strategies in canine cancer (opens in a new tab) Download PDF for An investigation of telomerase-based diagnostic and therapeutic strategies in canine cancer (opens in a new tab)

  3. Dietary Vitamin D Intake and Vitamin D Status in Canine Cancer Patients

    … D status have been linked to increased risk of cancer development. This association is starting to be explored in canines. This thesis is an investigation of the dietary vitamin D intake and vitamin D status of dogs with cancer, specifically osteosarcoma, lymphoma and mast cell tumours, in …

    guelph Repository record for Dietary Vitamin D Intake and Vitamin D Status in Canine Cancer Patients (opens in a new tab)

  4. Internal dosimetric evaluation of Cu-64-ATSM in canine cancer bearing patients

    … Tomography (PET/CT) imaging agent with cancer theranostic potential. In this study, the PET/CT images of two cancer bearing canine patients treated with 64Cu-ATSM were used to create patient specific voxelized phantoms that were compatible with the Monte Carlo N Particle extended (MCNPX) …

    colostate Repository record for Internal dosimetric evaluation of Cu-64-ATSM in canine cancer bearing patients (opens in a new tab)

  5. Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer

    zurich

  6. Characterizations of chromosome aberrations, telomere dysfunction, and radiosensitivity signatures in canine cancer cell lines

    To view the abstract, please see the full text of the document.

    colostate Repository record for Characterizations of chromosome aberrations, telomere dysfunction, and radiosensitivity signatures in canine cancer cell lines (opens in a new tab)

  7. An Exploration of the Initial Canine Cancer Cellular Response to Treatment with the Novel Fc3TSR Therapeutic

    … hypothesize that Fc3TSR will induce apoptosis in canine cancer cells, and that CD36 will mediate this effect. Cellular viability assays show that Fc3TSR causes a significant cytotoxic effect in canine cell lines cultures of lung adenocarcinoma, melanoma, and osteosarcoma, but not in …

    guelph Repository record for An Exploration of the Initial Canine Cancer Cellular Response to Treatment with the Novel Fc3TSR Therapeutic (opens in a new tab)

  8. Overactive NF-KB signaling as a druggable target and evaluation of parthenolide an NF-KB inhibitor in canine cancer

    … (MCT). Lymphoma is one of the most common cancer types affecting dogs and humans, and therefore, novel therapeutic approaches are always needed. For all of these cancer types, dogs and human cancers share common molecular abnormalities, consistent with a conserved pathogenesis between …

    colostate Repository record for Overactive NF-KB signaling as a druggable target and evaluation of parthenolide an NF-KB inhibitor in canine cancer (opens in a new tab)

  9. Utilization of a canine cancer cell line (FACC) panel in comparative and translational studies of gene expression and drug sensitivity

    Canine cancer is the leading cause of death in adult dogs. The use of the canine cancer model in translational research is growing in popularity due to the many biologic and genetic similarities it shares with human cancers. Cancer cell tissue culture has long been an established tool for expanding …

    colostate Repository record for Utilization of a canine cancer cell line (FACC) panel in comparative and translational studies of gene expression and drug sensitivity (opens in a new tab)

  10. Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours and the influence of age, breed, body size, sex and castration status on tumour development in dogs in Switzerland from 1955-2008

    This retrospective study presents the Swiss Canine Cancer Registry, containing pathology diagnostic records compiled between 1955 and 2008 by three veterinary diagnostic laboratories in Switzerland. The data set was investigated systematically covering various points of interest. The results were …

    zurich

  11. Efficacy of approved Smallpox Vaccines in Human and Canine Cancer Therapy: Adipose - tissue derived Stem Cells (ADSC) take up VACV and serve as a protective vehicle for virus delivery to tumors

    Cancer is one of the major causes of mortality in developed countries. In 2020, there were more than 19.3 million new cases of tumor malignancies worldwide, with more than 10 million deaths. The high rates of cancer cases and mortality necessitate extensive research and the development of novel …

    wurz-thes Repository record for Efficacy of approved Smallpox Vaccines in Human and Canine Cancer Therapy: Adipose - tissue derived Stem Cells (ADSC) take up VACV and serve as a protective vehicle for virus delivery to tumors (opens in a new tab)

  12. Novel approach to cancer therapeutics using comparative cancer biology

    Developing personalized cancer therapies based on cancer genomics methodologies forms the basis for future cancer therapeutics. A genomics platform was developed based on canine cancer to produce a proof-of-concept for personalized genomics led therapeutic choices but also developing personalized …

    edinburgh Repository record for Novel approach to cancer therapeutics using comparative cancer biology (opens in a new tab)

  13. Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains

    … clinical trials for the treatment of various cancers. Oncolytic viruses selectively infect and replicate in cancer cells, destroying tumor tissue via cell lysis, while leaving noncancerous tissues unharmed. Vaccinia virus (VACV) is arguably one of the safest viruses, which has been intensively …

    wurz-thes Repository record for Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains (opens in a new tab)

  14. Development of telomerase targeted gene therapy for treatment of cancer

    … and ineffective in vivo transgene delivery. Cancer is one of the leading diseases to cause death in the human and canine population. For this reason gene therapy has been studied as a potential novel treatment for cancer. Two step transcriptional amplification system is a system applied to …

    glasgow Repository record for Development of telomerase targeted gene therapy for treatment of cancer (opens in a new tab) Download PDF for Development of telomerase targeted gene therapy for treatment of cancer (opens in a new tab)

  15. Development of PAC-1 as a privileged agent for combination chemotherapy

    Elucidation of the molecular mechanisms of cancers has enabled the development of molecularly targeted chemotherapeutics capable of exploiting cancer-specific cellular alterations. Small-molecule activation of procaspase-3 represents a particularly promising opportunity, based upon its determinant …

    uiuc Repository record for Development of PAC-1 as a privileged agent for combination chemotherapy (opens in a new tab)

  16. Avaren-Fc's effects on lymphoma cells.

    … with a human B-cell lymphoma cell line, a canine B-cell lymphoma cell line, healthy canine peripheral blood mononuclear cells (PBMCs), and healthy human PBMCs. AvFc was shown to exhibit significant binding to human lymphoma cells. Furthermore, the direct cytotoxicity of Avaren-Fc against …

    louisville Repository record for Avaren-Fc's effects on lymphoma cells. (opens in a new tab)

  17. Canine T-regulatory cells in aging and cancer : quantifying a unique T cell subset

    … host susceptibility to infectious diseases and cancer, allowing these disease processes to escape normal immune surveillance. There are numerous human studies documenting not only an increase %Tregs in cancer patients, but also correlation with negative prognostic factors and overall survival …

    missouri Repository record for Canine T-regulatory cells in aging and cancer : quantifying a unique T cell subset (opens in a new tab)

  18. Effects of survivin and survivin inhibition in canine models of lymphoma and osteosarcoma

    Canine lymphoma (LSA) and osteosarcoma (OS) have high mortality rates and remain in need of more effective therapeutic approaches. Survivin, an IAP (inhibitor of apoptosis) family member protein that inhibits apoptosis and drives cell proliferation, is commonly elevated in human and canine cancer. …

    colostate Repository record for Effects of survivin and survivin inhibition in canine models of lymphoma and osteosarcoma (opens in a new tab)

Page 1 of 3